This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management
Cell Death Discovery Open Access 17 June 2022
-
The role of ubiquitination in tumorigenesis and targeted drug discovery
Signal Transduction and Targeted Therapy Open Access 29 February 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
ORIGINAL RESEARCH PAPER
Licchesi, J. D. F. et al. An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains. Nature Struct. Mol. Biol. 11 Dec 2011 (doi:10.1038/nsmb.2169)
FURTHER READING
Komander, D., Clague, M. J. & Urbé, S. Breaking the chains: structure and function of the deubiquitinases. Nature Rev. Mol. Cell Biol. 10, 550–563 (2009)
Rights and permissions
About this article
Cite this article
David, R. DUBs' key to selectivity. Nat Rev Mol Cell Biol 13, 64–65 (2012). https://doi.org/10.1038/nrm3268
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm3268
This article is cited by
-
Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management
Cell Death Discovery (2022)
-
The role of ubiquitination in tumorigenesis and targeted drug discovery
Signal Transduction and Targeted Therapy (2020)